Skip to main content

Stigmabase | HIV

Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

|

Flu Drugs Show Promise Against Cognitive Decline, Aging-Related Diseases

South Africa Time — Wednesday, June 10, 2026

Study in people with HIV and mice identifies new mechanism—and drug target—for memory decline.

View article...

Racial Xperience

Top stories of the last 30 days

Misinformation threatens rollout of HIV prevention drug lenacapavir

South Africa Time — Wednesday, May 27, 2026

Health experts say false claims about the lenacapavir injection could undermine efforts to reduce new HIV infections in South Africa. View article...

Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients ...

South Africa Time — Thursday, May 28, 2026

In this study, HIV-infected patients who are receiving antiretroviral therapy for HIV will receive either maraviroc or a placebo (sugar pill) each day ... View article...

Genotypic challenges in implementing broadly neutralizing antibody-based long-acting HIV ...

South Africa Time — Thursday, May 28, 2026

Broadly neutralizing antibodies (bnAbs) against HIV-1 are promising components of long-acting antiretroviral treatment (ART) due to their ... View article...

Immuno Cure Deploys Scientist Team to Manage Research Facility for Therapeutic DNA ...

South Africa Time — Wednesday, May 27, 2026

... HIV infection, with over 44.1 million people living with HIV globally. While antiretroviral therapy can effectively control HIV replication, it ... View article...

Small study hints that revving up immune cells might help fight HIV

South Africa Time — Thursday, May 14, 2026

Scientists are supercharging patients' own immune cells to try to fight HIV without today's drugs. A small study is hinting that CAR-T cell ... View article...

Misinformation is coming for the anti-HIV jab. Let's get ahead of it

South Africa Time — Monday, May 25, 2026

A new HIV prevention injection could change the course of the epidemic — but only if people trust it. Research shows we can pre-empt the false ... View article...

Integrating HIV Prevention Tools for Men

South Africa Time — Thursday, May 28, 2026

HIV continues to be a major public health challenge in Sub-Saharan Africa, where a large share of global infections still occur. View article...

Against all odds: 42-year-old woman defeats HIV, hepatitis B and cancer with rare liver transplant

South Africa Time — Monday, May 25, 2026

For years, individuals suffering from HIV along with serious liver disease or cancer were regarded as inappropriate candidates for undergoing an ... View article...

JOHANNESBURG

Stigmabase is a canadian non-profit internet initiative dedicated to informing and raising awareness on the damaging effects of social exclusion and stigma around the world. The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

Powered by Blogger

2010 - 2026 ― Stigmabase Global Initiative || Keeping up-to-date on global exclusion

Top stories of the last 7 days

GLP-1 drugs like Ozempic, Wegovy may help slow biological aging

South Africa Time — Wednesday, June 10, 2026

In a trial of adults living with HIV , participants receiving semaglutide showed slower progression of several epigenetic markers associated with ... View article...

Western Cape secures 29,000 doses of groundbreaking twice-yearly HIV prevention drug

South Africa Time — Monday, June 08, 2026

The twice-yearly HIV prevention option was added to the country's existing oral prevention offerings. View article...

15000 doses of injectable PrEP for HIV protection to arrive through PH-US deal

South Africa Time — Monday, June 08, 2026

... HIV transmission by more than 99.9%, though it is technically a chemical drug rather than a vaccine because it does not train the immune system. View article...

Will HIV Win and Lung Cancer Loss in Trials Recast Merck's (MRK) Risk Reward Narrative?

South Africa Time — Tuesday, June 09, 2026

In early June 2026, Gilead Sciences and Merck reported that their investigational once-weekly oral HIV regimen of islatravir/lenacapavir met the ... View article...

Philippines secures 15,000 doses of injectable prep amid rising HIV infections

South Africa Time — Monday, June 08, 2026

... Lenacapavir (LEN) through a joint initiative with the United States Department of State to combat the country's rising HIV infection rates. View article...

Most cases of HIV persistence in blood following treatment explained by defective copies of the virus

South Africa Time — Monday, June 08, 2026

A study based on blood samples strongly suggests that most persistent cases of viral detection, despite ideal HIV drug therapy, are not due to ... View article...

South Africa moves to eliminate HIV threat with Lenacapavir rollout

South Africa Time — Monday, June 08, 2026

Making the HIV prevention medicine available to South Africans was one of the commitments the President made in the State of the Nation Address (SONA) ... View article...

Study explains why HIV sometimes persists in blood post-treatment

South Africa Time — Tuesday, June 09, 2026

... antiretroviral drug therapy. These samples, which were assessed from 32 ... Modern antiretroviral therapies, which date back to 1996, prevent ... View article...

ABOUT STIGMABASE
Request for Review

Total Pageviews